SynthesisInternational journal of clinical pharmacy2022

Efficacy and treatment-related adverse events of multi-targeted tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials.

Keqian Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.